The MRCT Center
The MRCT Center is a research and policy center associated with two of the world’s most respected names in healthcare and academia: Brigham and Women’s Hospital and Harvard University.
We function as an independent convening group to bring together collaborative multidisciplinary teams to identify expert stakeholders from industry, academia, advocacy groups, nonprofit organizations, and regulatory agencies to address critical issues in the conduct and oversight of clinical trials. We engage patients and participants throughout all stages of our work.
Our efforts have resulted in the implementation of improved clinical research practices, greater transparency, clearer communication, increased diversity and inclusion, and improved safety for research participants.
Our Vision
Improve the integrity, safety, and rigor of global clinical trials
Our Mission
Engage diverse stakeholders to define emerging issues in global clinical trials and to create and implement ethical, actionable, and practical solutions.
History
Founding – The “MRCT Project” was initiated in 2009 by Pfizer Inc. at a summit meeting held at Harvard University with a group of diverse stakeholders. The output of the summit meeting culminated in a report of recommendations that led to the establishment of the Multi-Regional Clinical Trials (MRCT) Center. The report also served as the blueprint for the Center’s first three initiatives. The mission of the MRCT Center was to focus on the design, conduct, and oversight of multi-regional clinical trials, emphasizing those issues involving emerging economies.
Expansion – Starting in 2010, additional industry, non-profit and academic stakeholders joined the MRCT Center as members of the Executive and Steering Committee, forming a diverse stakeholder community of like-minded organizations to address the common challenges associated with globalization of clinical trials. The MRCT Center was administratively located at the Harvard Global Health Institute, under the Provost’s Office at Harvard University, with offices in Harvard Square. Numerous projects and workstreams were launched, including Post-Trial Access to Medicines, Return of Results, and Core Competencies in Clinical Research Professionals. In 2013, the MRCT Center launched a workstream to address data sharing and transparency that, among other issues, envisioned a platform to enable access to clinical trial data with the capacity to combine data sets. In 2017, the MRCT Center launched this platform as Vivli, a Center for Global Data Sharing, that was incorporated as a separate 501(c)(3) entity.
Today – The MRCT Center is located on the Harvard University campus and at the Brigham and Women’s Hospital and is administratively associated with the Division of Global Health Equity at the Brigham and Women’s Hospital. The MRCT Center’s Faculty Director is a Professor of Medicine at the Harvard Medical School. Our Center collaborates in various ways with programs and individuals at both Harvard University and Brigham and Women’s Hospital. The Center leads numerous projects that seek to identify emerging challenges in global clinical trials and deliver ethical, actionable, and practical solutions for the global clinical trial enterprise. China, India, Mexico, Algeria, Indonesia, and the continent of Africa are among the many countries in which we worked in country and provided in-person or virtual training. The MRCT Center has trained representatives from 25 countries and offers online training in good clinical practices that has reached over 100 countries. Our collaborative community includes approximately 6,000 people from 90 countries.
Access to Resources and Tools – Since the mission of the MRCT Center is to impact the emerging and developing world, our resources and tools are, most often, freely and openly available.
